SIX1/EYA1 are novel liver damage biomarkers in chronic hepatitis B and other liver diseases - Xu, Baoyan; Yang, Qiao; Tang, Yingzi; Tan, Zhaoxia; Fu, Haiyan; Peng, Jing; Xiang, Xiaomei; Gan, Linlin; Deng, Guohong; Mao, Qing; Xu, Pin-Xian; Jiang, Yi; et al. (Annals of Translational Medicine; Vol 9, No 12 (June 29, 2021): Annals of Translational Medicine, 2021)